You are here

Endocrinologie

Studies open voor deelname

Diabetes mellitus type 2

CONFIDENCE:

Een dubbelblinde fase 2-studie met behandeling in drie parallelgroepen ter beoordeling van de werkzaamheid en veiligheid van finerenone plus empagliflozine in vergelijking met finerenone of empagliflozine bij deelnemers met chronische nierziekte en diabetes type 2.

Toekomstige studies

Diabetes mellitus type 2

FINE-REAL:

A non-interventional study providing insights into the use of finerenone in a routine clinical setting

Zwangerschapsdiabetes

SERENA:

Semaglutide for the treatment of glucose intolerance in women with prior gestational diabetes:

a double blind RCT

Obesitas

Boehringer Ingelheim protocol 1404-0038

A Phase III, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity
without type 2 diabetes

Boehringer Ingelheim protocol 1404-0041: obesitas + T2DM

A Phase III, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity and
type 2 diabetes mellitus

Contact studieteam

Rina Talpe                              t 051 23 75 11
Laura Tanghe                         t 051 23 73 25
Els Verbruggen                      t 051 23 39 04

e  ctc.endo@azdelta.be